William Blair:下调Elevation Oncology评级

证券之星
Jun 10

William Blair:下调Elevation Oncology(ELEV.US)评级,由优于大市调整至大市一致评级。Elevation Oncology(ELEV.US)公司简介:Elevation Oncology Inc是一家肿瘤公司,专注于基因组定义患者群体癌症治疗的靶向疗法的开发。该公司的主导项目专注于神经调节蛋白1(NRG1)融合,这是一种罕见的基因组改变,具有通过靶向HER3抑制...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10